Patent Expiry

ARWR: REDEMPLO: recorded patent 12365899 expiry

Name: REDEMPLO: recorded patent 12365899 expiry
Start: 2038-09-10
End: 2038-09-10

September 10, 2038 · PLOZASIRAN SODIUM. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: September 10, 2038
Company: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Drug: PLOZASIRAN SODIUM

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Patent Expiry

REDEMPLO: recorded patent 12365899 expiry

September 10, 2038

ARWR overview →

Orange Book application NDA219947, product 001, listed patent 12365899 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source

Company: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Drug: PLOZASIRAN SODIUM